A new trading day began on Friday, with Structure Therapeutics Inc ADR (NASDAQ: GPCR) stock price down -9.34% from the previous day of trading, before settling in for the closing price of $37.69. GPCR’s price has ranged from $26.61 to $66.38 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 1.41%. With a float of $54.81 million, this company’s outstanding shares have now reached $57.25 million.
Let’s look at the performance matrix of the company that is accounted for 93 employees. In terms of profitability, gross margin is 11.91%, operating margin of -10705.09%, and the pretax margin is -8335.45%.
Structure Therapeutics Inc ADR (GPCR) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Structure Therapeutics Inc ADR is 4.27%, while institutional ownership is 102.15%.
Structure Therapeutics Inc ADR (GPCR) Performance Highlights and Predictions
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.16 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.23 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 1.41% per share during the next fiscal year.
Structure Therapeutics Inc ADR (NASDAQ: GPCR) Trading Performance Indicators
Here are Structure Therapeutics Inc ADR’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 27.63.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.21, a number that is poised to hit -0.23 in the next quarter and is forecasted to reach -1.16 in one year’s time.
Technical Analysis of Structure Therapeutics Inc ADR (GPCR)
Structure Therapeutics Inc ADR (NASDAQ: GPCR) saw its 5-day average volume 0.78 million, a negative change from its year-to-date volume of 0.78 million. As of the previous 9 days, the stock’s Stochastic %D was 19.05%. Additionally, its Average True Range was 2.55.
During the past 100 days, Structure Therapeutics Inc ADR’s (GPCR) raw stochastic average was set at 10.73%, which indicates a significant increase from 3.67% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 66.41% in the past 14 days, which was higher than the 61.67% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $39.38, while its 200-day Moving Average is $40.06. Nevertheless, the first resistance level for the watch stands at $36.65 in the near term. At $39.12, the stock is likely to face the second major resistance level. The third major resistance level sits at $40.49. If the price goes on to break the first support level at $32.81, it is likely to go to the next support level at $31.44. Assuming the price breaks the second support level, the third support level stands at $28.97.
Structure Therapeutics Inc ADR (NASDAQ: GPCR) Key Stats
With a market capitalization of 1.96 billion, the company has a total of 57,197K Shares Outstanding. Currently, annual sales are 0 K while annual income is -89,620 K. The company’s previous quarter sales were 0 K while its latest quarter income was -26,030 K.
